Carl Zeiss Meditec AG english

EBIT more than quadrupled at EUR 5,8m - Sales and profit targets confirmed

Ad-hoc-announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
-----
(Jena, 14 February 2003) In the first quarter of the 2002/2003 financial
year
(ending 31 December 2002) Carl Zeiss Meditec AG was able to significantly
improve its profit situation. Compared to the same period last year,
earnings
before interest and taxes (EBIT) increased by 346% from EUR 1.3m to EUR
5.8m.
The net income for the first quarter significantly increased from 0.2m EUR
to
2.5m EUR. As a result, earnings per share are at EUR 0.10 (previous year:
EUR
0.01). The reasons for the significant increase are to be seen in the
further
expansion of the already dominant market position, consolidation effects
as well
 as realisation of the first synergies arising from the merger.

The sales volume rose by 34.9% to EUR 62.4m compared to EUR 46.2m. In the
course
 of the quarter cash assets increased from EUR 7.2m to EUR 10.0m. This is
attributable to operative cash flow, that amounted to EUR 2.0m (previous
year:
EUR -5.5m). The equity ratio increased to 50.3% (49.2%). Carl Zeiss Meditec
reaffirmes the target of about EUR 255m in sales for the current financial
year
and an EBIT of about EUR 20m.

Contact:
Carl Zeiss Meditec AG, Jens Brajer/Investor Relations, Göschwitzer Str.
51-52,
D-07745 Jena, Telefon +49 (0)3641-220-105, Fax: +49 (0)3641-220-102,
E-Mail:
investors@meditec.zeiss.com

end of ad-hoc-announcement  (c)DGAP 13.02.2003
---------------------------------------------------------------------------
-----
WKN: 531370; ISIN: DE0005313704; Index:
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in
Berlin,
Düsseldorf, Hamburg, Hannover, München und Stuttgart

140005 Feb 03